‘Pay-for-Delay’ Drug Case Moves Forward

The European Commission said smaller companies agreed to keep generics temporarily off the market in exchange for money from makers like Lundbeck.

Original - http://feeds.nytimes.com/click.phdo?i=2ff2c3721ec7898b4a5bff16d9d65458